WCC blog: secondary prevention is the low hanging fruit
One of the most interesting presentations at the World Congress of Cardiology in Melbourne this week was a talk by Professor Philip Aylward of Adelaide on how far we have come in the treatment of ACS.
It’s easy to forget, but in the era of Mad Men, the chances of surviving a heart attack were only 50/50. Now, with the optimum use of thrombolytics, antiplatelet drugs and stents mortality rates are as low as 4%. That’s an amazing improvement – but it also means cardiologists are victims of their own success. Faced with an increasing number of heart attack survivors, the new challenge is in